Mercer Global Advisors Inc Corcept Therapeutics Inc Transaction History

Mercer Global Advisors Inc

$45.6 Billion
Q3 2024

A detailed history of Mercer Global Advisors Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Mercer Global Advisors Inc holds 89,774 shares of CORT stock, worth $4.61 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

89,774

Previous 81,801 9.75%

Holding current value

$4.61 Million

Previous $2.66 Million 56.27%

% of portfolio

0.01%

Previous 0.01%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$29.51 - $46.26 $235,283 - $368,830	7,973 Added 9.75%	89,774 $4.15 Million
Q2 2024 Aug 12, 2024	BUY	$22.21 - $34.48 $236,714 - $367,487	10,658 Added 14.98%	81,801 $2.66 Million
Q1 2024 May 15, 2024	SELL	$21.1 - $27.46 $74,630 - $97,126	-3,537 Reduced 4.74%	71,143 $1.79 Million
Q4 2023 Feb 14, 2024	BUY	$24.82 - $32.88 $183,345 - $242,884	7,387 Added 10.98%	74,680 $2.43 Million
Q3 2023 Nov 13, 2023	BUY	$21.97 - $33.8 $321,728 - $494,967	14,644 Added 27.81%	67,293 $1.83 Million
Q2 2023 Aug 14, 2023	BUY	$21.44 - $25.15 $159,920 - $187,593	7,459 Added 16.51%	52,649 $1.17 Million
Q1 2023 May 15, 2023	BUY	$19.2 - $24.47 $63,859 - $81,387	3,326 Added 7.94%	45,190 $978,000
Q4 2022 Feb 08, 2023	BUY	$19.95 - $29.96 $15,940 - $23,938	799 Added 1.95%	41,864 $850,000
Q3 2022 Nov 15, 2022	BUY	$24.7 - $29.12 $81,139 - $95,659	3,285 Added 8.7%	41,065 $1.05 Million
Q2 2022 Aug 10, 2022	BUY	$17.33 - $25.3 $83,478 - $121,870	4,817 Added 14.61%	37,780 $898,000
Q1 2022 May 10, 2022	BUY	$16.53 - $25.21 $111,742 - $170,419	6,760 Added 25.8%	32,963 $742,000
Q4 2021 Feb 04, 2022	BUY	$17.1 - $23.34 $50,684 - $69,179	2,964 Added 12.75%	26,203 $519,000
Q3 2021 Nov 10, 2021	BUY	$19.68 - $22.53 $28,437 - $32,555	1,445 Added 6.63%	23,239 $457,000
Q2 2021 Aug 10, 2021	BUY	$19.97 - $24.43 $30,813 - $37,695	1,543 Added 7.62%	21,794 $479,000
Q1 2021 May 11, 2021	BUY	$23.49 - $30.56 $50,386 - $65,551	2,145 Added 11.85%	20,251 $482,000
Q4 2020 Feb 12, 2021	BUY	$16.78 - $27.3 $45,054 - $73,300	2,685 Added 17.41%	18,106 $474,000
Q3 2020 Dec 10, 2020	BUY	$12.46 - $19.98 $40,146 - $64,375	3,222 Added 26.41%	15,421 $268,000
Q2 2020 Aug 10, 2020	BUY	$11.0 - $18.26 $134,189 - $222,753	12,199 New	12,199 $205,000

Others Institutions Holding CORT

# of Institutions

346

Shares Held

86.1M

Call Options Held

1.12M

Put Options Held

667K

View Full List

About CORCEPT THERAPEUTICS INC

Ticker CORT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,105,000
Market Cap $5.51B
Description
Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...

More about CORT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mercer Global Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Mercer Global Advisors Inc with notifications on news.

Account

Mercer Global Advisors Inc Corcept Therapeutics Inc Transaction History